ISDA

Entry Detail

PDB ID:

3KWF

Keywords:

Title:

human DPP-IV with carmegliptin (S)-1-((2S,3S,11bS)-2-Amino-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-3-yl)-4-fluoromethyl-pyrrolidin-2-one

Biological Source:

Source Organism:

Homo sapiens

PDB Version:

Deposition Date:

2009-12-01

Release Date:

2010-01-12

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.40 Å

R-Value Free:

0.24

R-Value Work:

0.19

R-Value Observed:

0.20

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Dipeptidyl peptidase 4
Chain IDs:A, B
Chain Length:728
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:P27487 Pfam ID:PF00930, PF00326 EC:3.4.14.5

Modified Residue

Compound ID	Chain ID	Parent Comp ID	Details	2D Image
ASN	B	ASN	GLYCOSYLATION SITE

Ligand Molecules

B1Q

NAG

Primary Citation

Discovery of carmegliptin: A potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

Mattei, P, Boehringer, M, Di Giorgio, P, Fischer, H, Hennig, M, Huwyler, J, Kocer, B, Kuhn, B, Loeffler, B.M, Macdonald, A, Narquizian, R, Rauber, E, Sebokova, E, Sprecher, U.Show

Bioorg.Med.Chem.Lett. 20 1109 1113 (2010)

PMID: 20031405 DOI: 10.1016/j.bmcl.2009.12.024

Abstact

Design, synthesis, and SAR are described for a class of DPP-IV inhibitors based on aminobenzo[a]quinolizines with non-aromatic substituents in the S1 specificity pocket. One representative thereof, carmegliptin (8p), was chosen for clinical development. Its X-ray structure in complex with the enzyme and early efficacy data in animal models of type 2 diabetes are also presented.

Legend

Protein

Chemical

Disease

Primary Citation of related structures